We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex ... Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. Show more
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...
IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...
Generated $24.7 million in net product sales of XDEMVY®, an 89% increase over Q4 2023, and delivered approximately 26,000 bottles of XDEMVY to patients Secured multiple commercial payer contracts...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.04 | 0.143061516452 | 27.96 | 28.45 | 26.42 | 561857 | 27.38977108 | CS |
| 4 | 2.14 | 8.27532869296 | 25.86 | 31.3 | 24.42 | 757329 | 27.60721817 | CS |
| 12 | -3.36 | -10.7142857143 | 31.36 | 42.5 | 24.42 | 661981 | 31.1781298 | CS |
| 26 | 2.46 | 9.63194988254 | 25.54 | 42.5 | 24.42 | 692872 | 32.17752166 | CS |
| 52 | 3.57 | 14.6131805158 | 24.43 | 42.5 | 12.57 | 637623 | 25.60720684 | CS |
| 156 | 1.87 | 7.15652506697 | 26.13 | 42.5 | 10.8001 | 283600 | 23.30928169 | CS |
| 260 | 9.7 | 53.0054644809 | 18.3 | 63.69 | 10.8001 | 239716 | 23.96296636 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
